UnitedHealth Q4 EPS $2.11 Beats by $0.02 but Falls 69% Year-Over-Year
UnitedHealth reported fourth-quarter 2025 adjusted EPS of $2.11, beating the $2.09 consensus by $0.02 but plunging 69% year over year as rising medical costs and declining risk-based membership weighed on results. Optum Rx and commercial fee-based membership growth provided offsetting strength despite a drop in risk-based enrollment.
1. Q4 2025 Earnings Results
UnitedHealth’s fourth-quarter adjusted EPS came in at $2.11 versus a $2.09 consensus estimate, marking a year-over-year decline of 69% from $6.74 in Q4 2024. Total revenue trends mirrored cost pressures, with elevated benefit expenses and a drop in risk-based membership offsetting growth in other areas.
2. Segment Performance Drivers
Optum Rx delivered robust performance through higher pharmacy volumes and commercial fee-based membership expanded, partially cushioning the impact of rising medical costs. The company’s risk-based membership contracted, contributing to elevated medical cost ratios that eroded profitability.
3. Membership and Cost Dynamics
Risk-based membership decline intensified benefit expense ratios in Q4, while overall medical membership trends reflected a pullback in higher-margin enrollee segments. Total operating costs increased, driven largely by the elevated benefits expense ratio, which rose above management targets.
4. Outlook Considerations
Management highlighted continued emphasis on cost management and membership growth in lower-risk segments as priorities for 2026. Investors will watch upcoming guidance for indications on margin stabilization and membership trajectory.